Trial Profile
A study of OXE-103 in concussion patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2016
Price :
$35
*
At a glance
- Drugs Ghrelin (Primary)
- Indications Concussion
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2016 New trial record